 Sharda IspatIron & Steel Products | Outcome of Board Meeting.29 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | +27.2% +16.0% +8.5% | ₹147 | 75 Cr | 12.0vs 16.9 | 12.6% | +64.4% |
 Polylink PolymersPetrochemicals | Audited Financial Results of the Company for the Quarter and Financial Year Ended on 31st March, 2026 along with Statement of Asset & Liability and Cash Flow Statement of the Company as ....29 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +17.4% +7.0% +19.4% | ₹22.6 | 50 Cr | 41.1vs 20.6 | 3.7% | -8.7% |
 Edvenswa EnterprisesComputers - Software & Consulting | Audited Standalone &Consolidated Financial Result for the Year ended March 31,2026.28 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -9.7% -18.7% -20.7% | ₹20.99 | 61 Cr | 26.6vs 19.5 | 3.8% | +0.9% |
 Tyche IndustriesPharmaceuticals | Board of Directors at its meeting held today i.e., 28th May 2026 has re-appointed the Internal Auditor and Cost Auditor of the Company for the F.Y. 2026-2728 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | +2.1% -3.9% -3.9% | ₹105 | 108 Cr | 15.7vs 28.5 | 6.7% | +31.0% |
 Uravi Defence &techAuto Components & Equipments | Audited(Standalone and Consolidated) Financial Results for the quarter and year ended 31st March,202628 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +1.4% +1.4% -1.1% | ₹110 | 125 Cr | 116.8vs 26.9 | 1.6% | -18.4% |
 Yuvraaj Hygiene ProductsHousehold Products | Audited Financial Results of the Company for the Quarter and Financial year ended March 31, 2026.28 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -2.8% -7.1% +7.6% | ₹8.5 | 79 Cr | 23.0vs 23.0 | 21.6% | +33.8% |
 Pavna IndustriesAuto Components & Equipments | Audited Financial Results for the quarter and year ended 31st March, 2026 alongwith the Audit Report as per Regulation 33 of SEBI (LODR) Regulations, 201528 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -7.1% -12.8% -2.0% | ₹18.48 | 258 Cr | 12.2vs 26.9 | 3.4% | -26.6% |
 Balaxi PharmaBALAXI | BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding "Update on the Company s First Pharmaceuticals Formulation Plant at Jadcherla, Hyderabad,"28 May 2026Pat NegativeEbitda Margin CompressionRevenue Decline×2 | +5.2% -1.3% -5.7% | ₹22.4 | 124 Cr | 65.9 | 1.8% | +25.9% |
 PMC FincorpNon Banking Financial Company (NBFC) | Audited Standalone Financial Results of the Company for the Quarter and year ended March 31, 202628 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -1.0% +2.1% -3.1% | ₹1.71 | 122 Cr | 19.0vs 17.5 | — | +14.5% |
 Themis MedicarePharmaceuticals | Please refer to the attachment.28 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -4.9% -5.4% -0.4% | ₹106 | 976 Cr | 25.7vs 28.5 | -2.8% | -1.9% |
 Nandan DenimOther Textile Products | Audited Financial Results for the Quarter and year ended on March 31, 2026 and other matters noted and approved.28 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -0.4% -2.3% -10.3% | ₹2.71 | 391 Cr | 15.1vs 15.3 | 5.5% | -31.2% |
 PokarnaGranites & Marbles | Pokarna Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 27, 202628 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -1.2% +0.3% +30.7% | ₹902 | 2,797 Cr | 30.4vs 17.2 | 8.4% | +24.3% |
 Deepak Fertilizers & PetrCommodity Chemicals | Statement of Audited Standalone and Consolidated Financial results for the quarter and year ended 31st March, 202628 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression×2 | -3.5% +4.9% +6.6% | ₹1,448 | 18,280 Cr | 32.5vs 17.5 | 8.4% | +0.2% |
 Adtech SystemsIndustrial Products | Audited Financial Results for quarter and year ended on 31st March 2026 and recommendation of dividend for FY 2025 2628 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -7.3% -8.9% -8.1% | ₹53 | 65 Cr | 29.3vs 23.8 | 8.8% | +33.5% |
 Ruchira PapersPaper & Paper Products | Declaration of Audited Financial Results for the year ended 31.03.2026 and Recommendation of Final Dividend28 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×3 | -8.2% -10.2% -12.2% | ₹103 | 306 Cr | 13.2vs 13.4 | 9.3% | +9.2% |
 Ceeta IndustriesPackaged Foods | This is for your Information and record.28 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -10.4% -17.1% -20.6% | ₹41.49 | 60 Cr | 103.7vs 31.1 | 2.8% | -21.5% |
 VMS IndustriesPort & Port services | Outcome of Board Meeting held on 28.05.2026 for approval of Fy 2025-26 with 4th quarter ended 31.03.202628 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -4.4% -12.8% -9.4% | ₹19.79 | 33 Cr | 12.1vs 14.6 | 2.2% | — |
 Wonder ElectricalsHousehold Appliances | As per attachment28 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -1.8% -1.1% +5.4% | ₹141 | 1,883 Cr | 219.5vs 57.6 | 9.4% | +164.8% |
 OM Freight ForwardersLogistics Solution Provider | Audited Financial Results for the Quarter and FY ended March 31, 2026 along with Auditors's Report thereon27 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×3 | -4.8% -7.0% +9.5% | ₹95 | 320 Cr | 18.2vs 16.2 | 9.2% | +31.4% |
 Bal PharmaPharmaceuticals | Bal Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.27 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression | -11.4% -9.4% -17.6% | ₹86.2 | 137 Cr | 17.4vs 28.5 | 4.7% | +13.6% |
 Capital TrustCAPTRUST | Results for upload27 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -9.7% -5.2% -14.0% | ₹19.45 | 32 Cr | 4.8 | — | -21.7% |
 Mudra Financial ServicesOther Financial Services | Enclosed herewith Audited Financial Results for the quater and year ended on March 31, 2026.27 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | pending | ₹4.73 | 2 Cr | 14.8vs 16.7 | — | -4.1% |
 Godavari DrugsPharmaceuticals | Company in its Board Meeting has approved financial results for period ended 31st march, 202627 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -4.6% -1.5% -9.4% | ₹101 | 102 Cr | 18.6vs 28.5 | 4.4% | +30.0% |
 Rajputana Investment and FinanNon Banking Financial Company (NBFC) | Approval of Standalone Audited Financial Result with Audit Report for the quarter and financial year ending 31.03.202627 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | pending | ₹29.5 | 9 Cr | 75.6vs 17.5 | 1.3% | -86.7% |
 West Coast Paper Mills LTPaper & Paper Products | West Coast Paper Mills Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.27 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression | -1.6% -0.8% +2.8% | ₹635 | 4,194 Cr | 26.6vs 13.4 | 5.0% | +19.4% |
 Dhunseri InvestmentsNon Banking Financial Company (NBFC) | Financial Results for the Quarter and Year ended 31st March 202627 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -6.4% -13.9% -3.2% | ₹980 | 598 Cr | — | — | -32.6% |
 Kirloskar Electric COKECL | Kirloskar Electric Company Limited has submitted to the Exchange, outcome of the Board meeting including the IND AS audited financial results for the quarter and year ended March 31, 2026.26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -8.0% -17.8% -10.1% | ₹133 | 883 Cr | 125.4 | 3.9% | +15.1% |
 Oil And Natural Gas Corp.Oil Exploration & Production | Oil & Natural Gas Corporation Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -7.5% -7.9% -18.6% | ₹236 | 2.97 L Cr | 7.1vs 42.5 | 10.4% | +10.1% |
 LincStationary | Audited Financial Results for quarter and financial year ended 31st March, 202626 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×3 | -3.2% -4.7% +13.3% | ₹96.55 | 574 Cr | 17.6vs 11.8 | 17.4% | -1.0% |
 Kamdhenu VenturesPaints | Kamdhenu Ventures Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -7.6% -9.7% -12.9% | ₹4.53 | 149 Cr | — | 0.3% | +32.1% |
 Suraj ProductsIron & Steel Products | Board Meeting outcome26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +11.0% +14.9% +8.0% | ₹255 | 291 Cr | 20.6vs 16.9 | 13.9% | — |
 Honda I Power ProductIndustrial Products | Honda India Power Products Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +4.8% -3.9% -4.3% | ₹2,080 | 2,109 Cr | 24.2vs 23.8 | 10.7% | +50.6% |
 CosynSoftware Products | Submission of outcome of Board Meeting held on even date to consider and approve the audited financial results for the quarter and year ended 31st March, 202626 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -7.0% -4.3% -3.1% | ₹23.9 | 18 Cr | 159.3vs 19.6 | 0.6% | -64.7% |
 Morepen Lab.Pharmaceuticals | Morepen Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -2.5% -3.6% +23.8% | ₹95.7 | 5,244 Cr | 61.4vs 28.5 | 8.3% | +17.8% |
 Kuantum PapersPaper & Paper Products | AUDITED FINANCIAL RESULTS FOR QUARTER/FINANCIAL YEAR ENDED 31ST MARCH, 202626 May 2026Pat NegativeEbitda Margin CompressionRevenue Decline×5 | -3.9% -6.2% -3.8% | ₹74.1 | 647 Cr | 16.3vs 13.4 | 2.8% | +7.6% |
 Lesha IndustriesTrading & Distributors | Outcome of Board Meeting_Audited Financial Results_31.03.202626 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -1.1% -8.6% -14.0% | ₹0.75 | 21 Cr | — | 0.3% | +451.5% |
 Sunrise Industrial TradersOther Financial Services | Integrated Filing (Financial) for quarter and year ended 31st March 2626 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | pending | ₹7.5 | 0 Cr | 0.2vs 16.7 | — | -32.1% |
 Responsive IndustriesFurniture Home Furnishing | Outcome of Board Meeting on Financial Results and Dividend26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +11.4% +3.9% +12.4% | ₹154 | 4,111 Cr | 45.4vs 37.9 | 9.2% | +37.2% |
 Fermenta BiotechPharmaceuticals | Annual General Meeting, Financial Results and Dividend26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -3.6% +10.4% +15.6% | ₹478 | 1,371 Cr | 19.1vs 28.5 | 21.7% | -13.1% |
 Yuken IndiaCompressors Pumps & Diesel Engines | Approval of Audited Financial Results for the quarter and year ended March 31, 202626 May 2026Pat NegativeEbitda Margin CompressionRevenue Decline | -1.6% +0.7% +7.9% | ₹969 | 1,316 Cr | 124.2vs 44.6 | 5.2% | +18.3% |
